224 related articles for article (PubMed ID: 29187387)
1. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; Orsel JG; Westenbrink BD; Brunner-la Rocca HP; van Miltenburg AJM; Boersma E; Hillege HL; Akkerhuis KM;
J Am Coll Cardiol; 2017 Nov; 70(19):2378-2388. PubMed ID: 29096809
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
van der Velde AR; Gullestad L; Ueland T; Aukrust P; Guo Y; Adourian A; Muntendam P; van Veldhuisen DJ; de Boer RA
Circ Heart Fail; 2013 Mar; 6(2):219-26. PubMed ID: 23395934
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
[TBL] [Abstract][Full Text] [Related]
7. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
[TBL] [Abstract][Full Text] [Related]
8. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure.
Zhang Y; Zhang R; An T; Huang Y; Guo X; Yin S; Wang Y; Ji S; Lv R; Zhang J; Maisel A
J Card Fail; 2015 Jan; 21(1):51-9. PubMed ID: 25463412
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.
Meijers WC; Januzzi JL; deFilippi C; Adourian AS; Shah SJ; van Veldhuisen DJ; de Boer RA
Am Heart J; 2014 Jun; 167(6):853-60.e4. PubMed ID: 24890535
[TBL] [Abstract][Full Text] [Related]
10. Serial galectin-3 and future cardiovascular disease in the general population.
van der Velde AR; Meijers WC; Ho JE; Brouwers FP; Rienstra M; Bakker SJ; Muller Kobold AC; van Veldhuisen DJ; van Gilst WH; van der Harst P; de Boer RA
Heart; 2016 Jul; 102(14):1134-41. PubMed ID: 27084804
[TBL] [Abstract][Full Text] [Related]
11. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure.
Gürgöze MT; van Vark LC; Baart SJ; Kardys I; Akkerhuis KM; Manintveld OC; Postmus D; Hillege HL; Lesman-Leegte I; Asselbergs FW; Brunner-la-Rocca HP; van den Bos EJ; Orsel JG; de Ridder SPJ; Pinto YM; Boersma E
Circ Heart Fail; 2023 Jan; 16(1):e009526. PubMed ID: 36408685
[TBL] [Abstract][Full Text] [Related]
12. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
[TBL] [Abstract][Full Text] [Related]
13. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Felker GM; Fiuzat M; Shaw LK; Clare R; Whellan DJ; Bettari L; Shirolkar SC; Donahue M; Kitzman DW; Zannad F; Piña IL; O'Connor CM
Circ Heart Fail; 2012 Jan; 5(1):72-8. PubMed ID: 22016505
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
Meijers WC; de Boer RA; van Veldhuisen DJ; Jaarsma T; Hillege HL; Maisel AS; Di Somma S; Voors AA; Peacock WF
Eur J Heart Fail; 2015 Dec; 17(12):1271-82. PubMed ID: 26466857
[TBL] [Abstract][Full Text] [Related]
17. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
Srivatsan V; George M; Shanmugam E
Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
[TBL] [Abstract][Full Text] [Related]
18. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
[TBL] [Abstract][Full Text] [Related]
19. The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure.
Miró Ò; González de la Presa B; Herrero-Puente P; Fernández Bonifacio R; Möckel M; Mueller C; Casals G; Sandalinas S; Llorens P; Martín-Sánchez FJ; Jacob J; Bedini JL; Gil V
Biomarkers; 2017 Dec; 22(8):731-739. PubMed ID: 28406038
[TBL] [Abstract][Full Text] [Related]
20. Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology.
Zhang M; Meng Q; Qi X; Han Q; Qi X; Wang F; Du B
Biomark Med; 2018 Nov; 12(11):1207-1217. PubMed ID: 30499308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
